Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22


Current practice of Dutch cardiologists in detecting and diagnosing atrial fibrillation: results of an online case vignette study.

Verbiest-van Gurp N, van Bladel PJM, van Kesteren HAM, Erkens PM, Stoffers HEJH.

Neth Heart J. 2017 Jun 19. doi: 10.1007/s12471-017-1010-3. [Epub ahead of print]


Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of "Gestalt" and the Wells Rule.

Hendriksen JM, Lucassen WA, Erkens PM, Stoffers HE, van Weert HC, Büller HR, Hoes AW, Moons KG, Geersing GJ.

Ann Fam Med. 2016 May;14(3):227-34. doi: 10.1370/afm.1930.


Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial.

Uittenbogaart SB, Verbiest-van Gurp N, Erkens PM, Lucassen WA, Knottnerus JA, Winkens B, van Weert HC, Stoffers HE.

Trials. 2015 Oct 23;16:478. doi: 10.1186/s13063-015-1006-5.


Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care.

Hendriksen JM, Geersing GJ, Lucassen WA, Erkens PM, Stoffers HE, van Weert HC, Büller HR, Hoes AW, Moons KG.

BMJ. 2015 Sep 8;351:h4438. doi: 10.1136/bmj.h4438. Review.


Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.

den Exter PL, van Es J, Kroft LJ, Erkens PM, Douma RA, Mos IC, Jonkers G, Hovens MM, Durian MF, ten Cate H, Beenen LF, Kamphuisen PW, Huisman MV; Prometheus Follow-Up Investigators.

Thromb Haemost. 2015 Jul;114(1):26-34. doi: 10.1160/TH14-10-0842. Epub 2015 May 28.


Qualitative point-of-care D-dimer testing compared with quantitative D-dimer testing in excluding pulmonary embolism in primary care.

Lucassen WA, Erkens PM, Geersing GJ, Büller HR, Moons KG, Stoffers HE, van Weert HC.

J Thromb Haemost. 2015 Jun;13(6):1004-9. doi: 10.1111/jth.12951. Epub 2015 May 9.


Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.

Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW.

Acad Emerg Med. 2015 Mar;22(3):299-307. doi: 10.1111/acem.12615. Epub 2015 Feb 25.


Alternative diagnoses in patients in whom the GP considered the diagnosis of pulmonary embolism.

Erkens PM, Lucassen WA, Geersing GJ, van Weert HC, Kuijs-Augustijn M, van Heugten M, Rietjens L, ten Cate H, Prins MH, Büller HR, Hoes AW, Moons KG, Oudega R, Stoffers HE.

Fam Pract. 2014 Dec;31(6):670-7. doi: 10.1093/fampra/cmu055. Epub 2014 Sep 12.


Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm.

Mos IC, Douma RA, Erkens PM, Kruip MJ, Hovens MM, van Houten AA, Hofstee HM, Kooiman J, Klok FA, Büller HR, Kamphuisen PW, Huisman MV; Prometheus Study Group.

Thromb Res. 2014 Jun;133(6):1039-44. doi: 10.1016/j.thromres.2014.03.050. Epub 2014 Apr 2.


Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.

Righini M, Van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, Sanchez O, Jaffrelot M, Trinh-Duc A, Le Gall C, Moustafa F, Principe A, Van Houten AA, Ten Wolde M, Douma RA, Hazelaar G, Erkens PM, Van Kralingen KW, Grootenboers MJ, Durian MF, Cheung YW, Meyer G, Bounameaux H, Huisman MV, Kamphuisen PW, Le Gal G.

JAMA. 2014 Mar 19;311(11):1117-24. doi: 10.1001/jama.2014.2135. Erratum in: JAMA. 2014 Apr 23-30;311(16):1694.


Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.

van Es J, den Exter PL, Kaptein AA, Andela CD, Erkens PM, Klok FA, Douma RA, Mos IC, Cohn DM, Kamphuisen PW, Huisman MV, Middeldorp S.

Thromb Res. 2013 Nov;132(5):500-5. doi: 10.1016/j.thromres.2013.06.016. Epub 2013 Oct 3.


Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism.

den Exter PL, van Es J, Erkens PM, van Roosmalen MJ, van den Hoven P, Hovens MM, Kamphuisen PW, Klok FA, Huisman MV.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1369-73. doi: 10.1164/rccm.201212-2219OC.


The additional value of the CRP test in patients in whom the primary care physician excluded pulmonary embolism.

Lucassen WA, Kuijs-Augustijn M, Erkens PM, Geersing GJ, Büller HR, van Weert HC.

Eur J Gen Pract. 2013 Sep;19(3):143-9. doi: 10.3109/13814788.2013.780019. Epub 2013 Apr 12.


Concerns in using multi-detector computed tomography for diagnosing pulmonary embolism in daily practice. A cross-sectional analysis using expert opinion as reference standard.

Lucassen WA, Beenen LF, Büller HR, Erkens PM, Schaefer-Prokop CM, van den Berk IA, van Weert HC.

Thromb Res. 2013 Feb;131(2):145-9. doi: 10.1016/j.thromres.2012.11.027. Epub 2012 Dec 13.


Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.

Erkens PM, ten Cate H, Büller HR, Prins MH.

PLoS One. 2012;7(9):e42269. doi: 10.1371/journal.pone.0042269. Epub 2012 Sep 25. Review.


Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study.

Geersing GJ, Erkens PM, Lucassen WA, Büller HR, Cate HT, Hoes AW, Moons KG, Prins MH, Oudega R, van Weert HC, Stoffers HE.

BMJ. 2012 Oct 4;345:e6564. doi: 10.1136/bmj.e6564.


Clinical decision rules for excluding pulmonary embolism: a meta-analysis.

Lucassen W, Geersing GJ, Erkens PM, Reitsma JB, Moons KG, Büller H, van Weert HC.

Ann Intern Med. 2011 Oct 4;155(7):448-60. doi: 10.7326/0003-4819-155-7-201110040-00007. Review.


Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?

Erkens PM, Gandara E, Wells PS, Shen AY, Bose G, Le Gal G, Rodger M, Prins MH, Carrier M.

Thromb Res. 2012 Jun;129(6):710-4. doi: 10.1016/j.thromres.2011.08.025. Epub 2011 Sep 9.


Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.

Douma RA, Mos IC, Erkens PM, Nizet TA, Durian MF, Hovens MM, van Houten AA, Hofstee HM, Klok FA, ten Cate H, Ullmann EF, Büller HR, Kamphuisen PW, Huisman MV; Prometheus Study Group.

Ann Intern Med. 2011 Jun 7;154(11):709-18. doi: 10.7326/0003-4819-154-11-201106070-00002.


Co-occurrence of metabolic factors and the risk of coronary heart disease: a prospective cohort study in the Netherlands.

Merry AH, Erkens PM, Boer JM, Schouten LJ, Feskens EJ, Verschuren WM, Gorgels AP, van den Brandt PA.

Int J Cardiol. 2012 Mar 8;155(2):223-9. doi: 10.1016/j.ijcard.2010.09.047. Epub 2010 Oct 20.


Supplemental Content

Loading ...
Support Center